SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-21-045337
Filing Date
2021-08-27
Accepted
2021-08-27 16:09:29
Documents
6
Effectiveness Date
2021-08-27

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea141705-s8_chinasxtpharma.htm S-8 69455
2 2021 EQUITY INCENTIVE PLAN ea141705ex4-2_chinasxt.htm EX-4.2 133550
3 OPINION OF CAMPBELLS ea141705ex5-1_chinasxt.htm EX-5.1 29651
4 CONSENT OF ZH CPA, LLC ea141705ex23-1_chinasxt.htm EX-23.1 5294
5 GRAPHIC ex5-1_001.jpg GRAPHIC 4205
6 GRAPHIC ex23-1_001.jpg GRAPHIC 6019
  Complete submission text file 0001213900-21-045337.txt   253290
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-259123 | Film No.: 211218994
SIC: 2834 Pharmaceutical Preparations